Assessing Grand Pharmaceutical Group (SEHK:512) Valuation After China Drug Approvals And Earnings UpdateSimplywall·Apr 5 at 12:43 PM00512-1.34%513700+0.35%
01:48 ETBelief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patientsprnewswire·Mar 23 at 12:50 AMCS精准医+1.78%000963-1.29%
Grand Pharmaceutical Wins China’s First Approval for Demodex Blepharitis Drug, Bolstering Ophthalmic PushTip Ranks·Mar 22 at 05:07 AM159929+0.68%588130+0.82%
East China Pharmaceutical Subsidiary Receives FDA Approval for Clinical TrialCoinLive·Mar 11 at 06:26 AM000963-1.29%
National Healthcare Security Administration: Key drug "Deferasirox" for treating "thalassemia" included in medical insurance36Kr·Jan 30 at 08:39 PM002038+4.46%512290+0.60%
Meow or never: China’s pudgy pets spark race for weight-loss drugsSCMP·Jan 6 at 06:30 PM000963-1.29%02196-0.30%
Is the moat of the weight loss miracle drug collapsing? Multiple pharmaceutical companies on three major platforms may be caught in a brutal price warWallstreetcn·Dec 30, 2025 at 08:57 AM000963-1.29%
China’s Huadong Medicine Gains After Ministry Accepts Application for Weight-Loss Drug for CatsYicai·Dec 30, 2025 at 05:50 AM000963-1.29%
HUADONG MEDICINE's innovative GLP-1/GIP dual-target long-acting agonist Pralmorelin injection's new veterinary drug registration application has been accepted by the Ministry of Agriculture and Rural AffairsWallstreetcn·Dec 29, 2025 at 03:10 AM000963-1.29%
